Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $207.00 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $207.00 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $12.84 | 1 | GlaxoSmithKline, LLC. ($12.84) |
| 2019 | $97.82 | 1 | GlaxoSmithKline, LLC. ($97.82) |
| 2018 | $12.20 | 1 | GlaxoSmithKline, LLC. ($12.20) |
| 2017 | $84.14 | 4 | GlaxoSmithKline, LLC. ($84.14) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/08/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: IMMUNOLOGY | ||||||
| 05/09/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $97.82 | General |
| Category: RESPIRATORY | ||||||
| 02/28/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2017 | GlaxoSmithKline, LLC. | INCRUSE (Drug) | Food and Beverage | In-kind items and services | $51.67 | General |
| Category: RESPIRATORY | ||||||
| 11/16/2017 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: RESPIRATORY | ||||||
| 08/23/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: RESPIRATORY | ||||||
| 02/01/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $10.61 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 12 | 17 | $2,006 | $244.80 |
| 2021 | 1 | 11 | 17 | $3,043 | $513.59 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 17 | $2,006 | $244.80 | 12.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 17 | $3,043 | $513.59 | 16.9% |
About Dr. Gerard Matysik, DO
Dr. Gerard Matysik, DO is a Pulmonary Disease healthcare provider based in Pella, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1750367124.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gerard Matysik, DO has received a total of $207.00 in payments from pharmaceutical and medical device companies, with $12.84 received in 2023. These payments were reported across 7 transactions from 1 company. The most common payment nature is "Food and Beverage" ($207.00).
As a Medicare-enrolled provider, Matysik has provided services to 23 Medicare beneficiaries, totaling 34 services with total Medicare billing of $758.39. Data is available for 2 years (2021–2022), covering 2 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Pella, IA
- Active Since 12/19/2005
- Last Updated 08/31/2022
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1750367124
Products in Payments
- TRELEGY ELLIPTA (Drug) $120.83
- INCRUSE (Drug) $51.67
- BREO (Drug) $21.66
- NUCALA (Biological) $12.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.